The current stock price of FORA is 2.15 USD. In the past month the price decreased by -4.87%. In the past year, price increased by 6.97%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 31.18 | 39.56B | ||
| DOCS | DOXIMITY INC-CLASS A | 31.42 | 9.70B | ||
| WAY | WAYSTAR HOLDING CORP | 26.28 | 6.74B | ||
| HTFL | HEARTFLOW INC | N/A | 2.38B | ||
| CERT | CERTARA INC | 19.36 | 1.54B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.34B | ||
| SDGR | SCHRODINGER INC | N/A | 1.31B | ||
| PHR | PHREESIA INC | N/A | 1.22B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.10B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | 633.71 | 1.07B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 7.83 | 930.04M | ||
| HSTM | HEALTHSTREAM INC | 36.66 | 739.67M |
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 1 full-time employees. The company went IPO on 2021-03-03. The firm is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The firm provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. The company has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
FORIAN INC
41 University Drive, Suite 400
Newtown PENNSYLVANIA US
Employees: 1
Phone: 12677578707
Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 1 full-time employees. The company went IPO on 2021-03-03. The firm is a provider of data science-driven information and analytics solutions to the life science, healthcare and financial services industries. The firm provides a suite of data management capabilities and proprietary information and analytics solutions to optimize and measure the operational, clinical and financial performance of customers. The company has expertise in acquiring, integrating, normalizing and commercializing large-scale healthcare data assets. Its data ingestion, transformation, delivery services and business intelligence platforms are managed entirely via cloud-based data centers located in the United States. The Company’s offerings include commercial, Real World Evidence (RWE) and market access solutions and proprietary data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company’s solutions include CHRONOS, Chartis, RWE and Kyber Data Science.
The current stock price of FORA is 2.15 USD. The price decreased by -2.27% in the last trading session.
FORA does not pay a dividend.
FORA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
7 analysts have analysed FORA and the average price target is 5.1 USD. This implies a price increase of 137.21% is expected in the next year compared to the current price of 2.15.
FORIAN INC (FORA) currently has 1 employees.
ChartMill assigns a technical rating of 3 / 10 to FORA. When comparing the yearly performance of all stocks, FORA turns out to be only a medium performer in the overall market: it outperformed 61.36% of all stocks.
ChartMill assigns a fundamental rating of 4 / 10 to FORA. FORA has a great financial health rating, but its profitability evaluates not so good.
Over the last trailing twelve months FORA reported a non-GAAP Earnings per Share(EPS) of -0.03. The EPS increased by 67.78% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1.87% | ||
| ROE | -2.93% | ||
| Debt/Equity | 0 |
7 analysts have analysed FORA and the average price target is 5.1 USD. This implies a price increase of 137.21% is expected in the next year compared to the current price of 2.15.
For the next year, analysts expect an EPS growth of 151% and a revenue growth 48.18% for FORA